期刊文献+

肝脏类器官的应用 被引量:1

Applications of liver organoids
原文传递
导出
摘要 在中国,肝病是因病死亡的主要原因之一.揭示肝脏疾病的发生发展机制,发现新的治疗靶点,以及建立医学治疗新方法,是关乎国计民生的重大课题.目前对于人类肝脏疾病的研究主要依赖于细胞系与动物模型,但是二维(two-dimensional, 2D)培养的细胞系缺少组织三维(three-dimensional, 3D)结构,而物种差异又限制了利用动物模型对人类肝脏疾病的进一步认识.类器官是一种新的体外培养系统,利用人类细胞构建的类器官体一方面能模拟体内器官的结构,另一方面体现了人类组织器官的功能,从而提供了新的研究模型.最近,肝脏类器官体技术也得到建立与发展,加深了人们对于肝脏疾病的认识,促进了药物靶点的研究,并催生了一些治疗方案的开发.本文将就肝脏类器官的疾病模拟和治疗应用进行综述. Liver disease is one of the leading causes of death in China. Unveiling the mechanisms of liver diseases, discovering new targets, and establishing new treatments are important issues. The current knowledge of human liver diseases is mainly derived from cell lines and animal models. However, two-dimensional(2D) cultured cells lack the three-dimensional(3D) structural features of the liver, and interspecies differences limit understanding of human cell-specific mechanisms using animal models. Organoids, as a new in vitro model, recapitulate the key structural and functional properties of human organs. Recently, liver organoids have been widely applied to understand liver diseases and facilitate the discovery and development of new treatments. Here, we review progresses in disease models and therapeutic applications of liver organoids.
作者 李春 章正涛 董双舒 惠利健 LI Chun;ZHANG ZhengTao;DONG ShuangShu;HUI Lijian(State Key Laboratory of Cell Biology,Shanghai Institute of Biochemistry and Cell Biology,Center for Excellence in Molecular Cell Science,Chinese Academyof Sciences,Shanghai200031,China;Universityof ChineseAcademyof Sciences,Beijing100049,China;School of Life Science and Technology,ShanghaiTech University,Shanghai 201210,China;Bio-Research Innovation Center,Shanghai Institute of Biochemistry and Cell Biology,Suzhou 215121,China;School of Life Science,Hangzhou Institute for Advanced Study,University of Chinese Academy of Sciences,Hangzhou 310024,China;Institute for Stem Cell and Regeneration,Chinese Academy of Sciences,Beijing 10010l,China)
出处 《中国科学:生命科学》 CSCD 北大核心 2023年第2期175-184,共10页 Scientia Sinica(Vitae)
基金 中国科学院“战略重点研究计划”(批准号:XDA16020201) 国家重点研发计划(批准号:2019YFA0802001,2019YFA0801503)资助。
关键词 肝脏类器官 疾病模型 药物筛选 liver organoids disease modeling drug screening
  • 相关文献

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部